Finger-Prick blood test could replace needles for cancer monitoring
NCT ID NCT07310537
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a small drop of blood from a finger-prick device can reliably detect tumor DNA in 35 adults with colorectal cancer that has spread to the liver. Researchers will compare results from the finger-prick sample to a standard arm-vein blood draw to see if they match. If successful, this could make cancer monitoring easier and less invasive for patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRCULATING TUMOR DNA (CTDNA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Erasmus MC University Medical Center
RECRUITINGRotterdam, South Holland, 3015 GD, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could prepared meals help colorectal cancer patients eat healthier?
- Less invasive ablation may rival surgery for liver tumors
- Can a common supplement stop colon polyps? new trial aims to find out
- Local hospital reviews colorectal cancer survival data
- Nerve block may speed recovery after colorectal cancer surgery
- Virtual art therapy tested to ease cancer anxiety